Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression
Authors:
Open Access
- 30 October 2023
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-13
Abstract
Adropin is encoded by the energy homeostasis-associated (ENHO) gene and widely present in liver, pancreas, heart, kidney, brain, and vascular tissues. Abnormal adropin is associated with metabolic, inflammatory, immune, and central nervous disorders. Whether adropin is involved in the development of colorectal cancer (CRC) is still unclear. Here, decreased adropin expression of tumor-nest cells in advanced-stage CRC was demonstrated. Adropin expressed by carcinoma cells was negatively correlated with macrophage infiltration in the matrix of CRC tissues. However, tumor macrophages enhanced adropin expression and were positively correlated with tumor invasion and metastasis. ENHO gene transfection into colon cancer (MC38) cells inhibited tumor growth in vivo, accompanying the increase of M1 macrophages. Treatment with low-dose adropin (< 100 ng/mL) on macrophages ex vivo directly increased mitochondrial reactive oxygen species for inflammasome activation. Furthermore, ENHO−/− mice had less M1 macrophages in vivo, and ENHO−/− macrophages were inert to be induced into the M1 subset ex vivo. Finally, low-dose adropin promoted glucose utilization, and high-dose adropin enhanced the expression of CPT1α in macrophages. Therefore, variations of adropin level in carcinoma cells or macrophages in tumor tissues are differently involved in CRC progression. Low-dose adropin stimulates the antitumor activity of macrophages, but high-dose adropin facilitates the pro-tumor activity of macrophages. Increasing or decreasing the adropin level can inhibit tumor progression at different CRC stages.Keywords
Funding Information
- National Natural Science Foundation of China (81873866, 82241043, 82272809)
This publication has 32 references indexed in Scilit:
- Macrophage plasticity, polarization, and function in health and diseaseJournal of Cellular Physiology, 2018
- G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2017
- Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung InjuryEBioMedicine, 2016
- Fatty acid oxidation in macrophage polarizationNature Immunology, 2016
- Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome ActivationJournal of Biological Chemistry, 2015
- Regulation of Substrate Oxidation Preferences in Muscle by the Peptide Hormone AdropinDiabetes, 2014
- Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2–M Cell-Cycle ProgressionMolecular Cancer Research, 2012
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid MetabolismCell Metabolism, 2008
- Physical mapping of the G-protein coupled receptor 19 (GPR19) in the chromosome 12p12.3 region frequently rearranged in cancer cellsHuman Genetics, 1999